Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes
Open Access
- 1 November 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 177 (9) , 6081-6090
Abstract
CD8 T cells lacking effector activity have been recovered from lymphoid organs of mice and patients with progressing tumors. We explored the basis for lack of effector activity in tumor-bearing mice by evaluating Ag presentation and CD8 T cell function in lymphoid organs over the course of tumor outgrowth. Early after tumor injection, cross-presentation by bone marrow-derived APC was necessary for T cell activation, inducing proliferation and differentiation into IFN-γ-producing, cytolytic effectors. At later stages of outgrowth, tumor metastasized to draining lymph nodes. Both cross- and direct presentation occurred, but T cell differentiation induced by either modality was incomplete (proliferation without cytokine production). T cells within tumor-infiltrated nodes differentiated appropriately if Ag was presented by activated, exogenous dendritic cells. Thus, activated T cells lacking effector function develop through incomplete differentiation in the lymph nodes of late-stage tumor-bearing mice, rather than through suppression of previously differentiated cells.Keywords
This publication has 50 references indexed in Scilit:
- Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4Nature Immunology, 2005
- PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T CellsCancer Research, 2004
- Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T CellsJournal of Experimental Medicine, 2003
- Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without ToleranceJournal of Experimental Medicine, 2002
- Cross-presentation in viral immunity and self-toleranceNature Reviews Immunology, 2001
- Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-AntigenJournal of Experimental Medicine, 2001
- Characterization of the ovalbumin‐specific TCR transgenic line OT‐I: MHC elements for positive and negative selectionImmunology & Cell Biology, 2000
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Identification of human cancers deficient in antigen processing.Journal of Experimental Medicine, 1993